Allergic rhinitis
MONDO:0011786Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.
Also known as: allergic form of rhinitis, allergic rhinitis, Perenial allergic rhinitis, atopic rhinitis, non-seasonal allergic rhinitis, perennial allergic rhinitis, seasonal allergic rhinitis, Alrh
147 clinical trials for this condition and its sub-types, 96 tagged with Allergic rhinitis itself.
Follow this condition to get notified about new trialsWhere it sits in the disease tree
Browse by category →Sub-types of Allergic rhinitis
-
Seasonal allergic rhinitis 45 trials
-
Perennial allergic rhinitis 28 trials
-
Vasomotor rhinitis 5 trials
-
Ancient gut therapy takes on allergies in new clinical trial
Disease control Not yet recruitingThis study tests whether an Ayurvedic treatment that targets digestion and gut health can reduce allergy symptoms and immune markers in people with allergic rhinitis (hay fever). 104 adults aged 18-40 with confirmed allergies will receive either the Ayurvedic treatment plus stand…
Sponsor: Amrita Vishwa Vidyapeetham • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
Massive asthma study tests phone apps and simple home fixes
Disease control Not yet recruitingThis large study aims to create a digital screening and management system for adults with asthma and allergies. Nearly 10,000 participants will use a smartphone platform to track symptoms and receive guidance on three non-drug strategies: avoiding allergens (like dust mites), inc…
Sponsor: Beijing Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New dissolving film could tame dust mite allergies without shots
Disease control Not yet recruitingThis study tests a daily dissolving film placed under the tongue to treat dust mite allergic rhinitis (hay fever). About 250 adults in China will use either the active film or a placebo for one year. The goal is to see if the film reduces sneezing, stuffiness, and the need for re…
Phase 2 • Sponsor: Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Could inhaled stem cell particles ease allergies and asthma?
Disease control Not yet recruitingThis early-phase trial is testing whether inhaling tiny particles from stem cells (called small extracellular vesicles) can safely help people with both allergic rhinitis and asthma. About 18 adults will receive either the active treatment or a placebo via nebulizer daily for two…
Sponsor: The Affiliated Hospital of Qingdao University • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Dust mite allergy test gets a tune-up in new study
Diagnosis Not yet recruitingThis study aims to find the best concentration of Blomia tropicalis (a type of dust mite) extract for allergy skin testing. About 30 adults with known dust mite allergies will receive small pricks with different extract strengths to see which causes a reaction similar to a standa…
Sponsor: Inmunotek S.L. • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
Cameras catch allergy relief: study puts faces under the lens
Symptom relief Not yet recruitingResearchers want to see whether facial photographs can show how well a fluticasone propionate nasal spray eases facial allergy symptoms. The study enrolls 16 adults with moderate to severe seasonal allergic rhinitis. Participants use the nasal spray and have their faces photograp…
Phase 4 • Sponsor: HALEON • Aim: Symptom relief
Last updated Sep 16, 2026 00:00 UTC
-
Can a needle in the face tame allergy symptoms?
Symptom relief Not yet recruitingThis trial asks whether adding a specific type of acupuncture—targeting a nerve bundle behind the nose—to a standard nasal steroid spray can ease allergic rhinitis symptoms like sneezing, congestion, and itching better than the spray alone. Adults with moderate-to-severe perennia…
Sponsor: Zhongshan Torch Development Zone People's Hospital • Aim: Symptom relief
Last updated Aug 30, 2026 00:00 UTC
-
New shot for teen hay fever? early trial underway
Symptom relief Not yet recruitingThis phase 2 trial tests the safety of stapokibart injection in 15 teenagers aged 12-17 with seasonal allergic rhinitis (hay fever). Participants receive the drug alongside their usual allergy treatments. The study focuses on side effects and how the body processes the drug, not …
Phase 2 • Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New nasal spray aims to unblock stuffy noses fast
Symptom relief Not yet recruitingThis study looks at how well RHINOSEDAL works for people aged 8 and older with a stuffy nose caused by colds, allergies, or sinus issues. About 126 participants will use the treatment as prescribed and report their symptoms over 6 days. The goal is to see if it provides meaningfu…
Sponsor: Laboratoires Elerte • Aim: Symptom relief
Last updated Jun 27, 2026 13:01 UTC
-
New allergy blocker spray could offer Drug-Free relief
Symptom relief Not yet recruitingThis study tests a new nasal spray called PL-14 Allergy Blocker in about 120 adults with seasonal allergies. Unlike regular allergy sprays, PL-14 is drug-free and works by forming a gel-like barrier in the nose to block allergens. The study compares it to a simple saline spray ov…
Sponsor: Polyrizon Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC
-
Surgery vs. meds: new study tests best way to treat Kids' allergies
Symptom relief Not yet recruitingThis study looks at whether removing the adenoids (with or without tonsils) can improve allergy symptoms in children aged 3 to 12 who also have enlarged adenoids and tonsils. Researchers will compare surgery to standard medication by tracking symptom scores and allergy markers in…
Sponsor: Tongji Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
Which allergy med combo works best? new study aims to find out
Symptom relief Not yet recruitingThis study compares two common treatment combinations for allergic rhinitis (hay fever) in adults: a nasal steroid spray plus an oral antihistamine versus a nasal steroid spray plus an oral antileukotriene. The goal is to see which combo better relieves symptoms like sneezing, st…
Phase 4 • Sponsor: Liaquat National Hospital & Medical College • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New allergy shot for teens enters early safety testing
Symptom relief Not yet recruitingThis early-stage study tests a new injection called JYB1904 in 12 teenagers aged 12-17 with allergies like hay fever, asthma, or food allergies. The main goal is to see if the drug is safe and how the body processes it. Participants will be closely monitored for side effects and …
Phase 1 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
New allergy shot under safety spotlight
Symptom relief Not yet recruitingThis study will test the safety of a new biologic drug called stapokibart, given as a shot, in 400 adults with seasonal allergic rhinitis (SAR). Participants are already prescribed the drug by their doctor. The main goal is to track any side effects. This is an open-label study, …
Sponsor: Chengdu Kangnuoxing Biopharma,Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New shot could quiet constant sniffles for months
Symptom relief Not yet recruitingThis study tests an injection called JYB1904 for people with year-round allergies (perennial allergic rhinitis). The goal is to see if it can reduce symptoms like runny nose, congestion, and sneezing better than a placebo. About 135 adults who already use nasal sprays will receiv…
Phase 2 • Sponsor: Jemincare • Aim: Symptom relief
Last updated Jun 27, 2026 11:00 UTC
-
New allergy drug AK139 aims to stop sneezing and stuffy noses
Symptom relief Not yet recruitingThis study tests a new medicine called AK139 for people with moderate to severe seasonal allergic rhinitis (hay fever). About 111 adults aged 18-65 with at least a 2-year history of seasonal allergies will receive either AK139 or a placebo. The main goal is to see if AK139 reduce…
Phase 2 • Sponsor: Akeso • Aim: Symptom relief
Last updated Jun 27, 2026 09:08 UTC
-
Which allergy med combo works best? new study aims to find out
Symptom relief Not yet recruitingThis study compares two ways to treat moderate to severe allergic rhinitis: using a nasal steroid spray plus an antihistamine nasal spray versus the same steroid spray plus an antihistamine pill. Fifty people aged 12 to 75 will be randomly assigned to one of the two treatments fo…
Phase 4 • Sponsor: China-Japan Union Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 08:05 UTC
-
New allergy shot strategy aims to stop sneezing and sniffling for good
Symptom relief Not yet recruitingThis study tests whether giving extra booster shots of allergy medicine directly into the tonsils can better control hay fever symptoms. About 276 adults with allergic rhinitis will receive either the standard three doses or additional boosters. Researchers will track symptom rel…
Sponsor: Renmin Hospital of Wuhan University • Aim: Symptom relief
Last updated Jun 27, 2026 08:02 UTC
-
Can salt water clear your Baby's stuffy nose? new study aims to find out
Symptom relief Not yet recruitingThis study looks at how well a saltwater (saline) nasal spray works and how safe it is for infants and toddlers aged 3 months to 4 years with stuffy noses from colds, flu, or allergies. About 83 children will use the spray for up to 14 days, and parents will report symptom change…
Sponsor: Laboratoires Quinton International S.L. • Aim: Symptom relief
Last updated Jun 27, 2026 08:01 UTC
-
New shot could tame hay fever misery
Symptom relief Not yet recruitingThis study tests an injection called GR1802, given alongside usual allergy treatments, to see if it can better control symptoms like sneezing, runny nose, and itchy eyes in people with seasonal allergic rhinitis (hay fever). About 144 adults who have had poor symptom control with…
Phase 3 • Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Can a natural spray beat dust mite allergies? new study aims to find out
Symptom relief Not yet recruitingThis study tests whether a natural nasal spray (Puressentiel Allergy Protection) can reduce symptoms of dust mite allergies. Twenty adults with dust mite allergic rhinitis will receive either the spray or a saline placebo before a nasal allergen challenge. Researchers will measur…
Sponsor: Puressentiel • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
Asthma drug could stop cat allergy sneezes in their tracks
Symptom relief Not yet recruitingThis small Phase 2 trial tests whether a single dose of zafirlukast, an asthma drug, can prevent nasal symptoms caused by cat dander. Twelve adults with cat allergies will receive either the drug or a placebo before being exposed to cat dander in a controlled setting. Their sympt…
Phase 2 • Sponsor: Allergy & Asthma Medical Group & Research Center • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC
-
Can a drop of timothy grass unlock the Eye-Nose allergy link?
Knowledge-focused Not yet recruitingResearchers at Queen's University are testing a method to safely trigger eye allergies in a research setting. They will apply timothy grass extract to the eyes of allergic and non-allergic volunteers, then measure symptoms and collect tear and nasal fluid samples. The goal is to …
Sponsor: Queen's University • Aim: Knowledge-focused
Last updated Sep 05, 2026 00:00 UTC
-
Allergy study seeks to pinpoint those most bothered by cats and birch pollen
Knowledge-focused Not yet recruitingThis study aims to identify and describe people with allergic conjunctivitis (eye allergies) caused by cats or birch tree pollen, with or without accompanying allergic rhinitis (hay fever). Researchers will collect information and perform allergy tests to see who qualifies for fu…
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
AI takes on air pollution: can it help europe breathe easier?
Knowledge-focused Not yet recruitingThis study uses artificial intelligence to understand how air pollution and climate change impact respiratory diseases like allergic rhinitis and asthma. Researchers will gather health data from about 1,900 patients across Europe and analyze it with AI tools to find better ways t…
Sponsor: Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:04 UTC